Literature DB >> 20111066

Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.

W G Morice, D Jevremovic, H Olteanu, A Roden, G Nowakowski, S Kroft, C A Hanson, P J Kurtin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20111066     DOI： 10.1038/leu.2009.304

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.

Authors:  Constance Baer; Shunsuke Kimura; Mitra S Rana; Andrew B Kleist; Tim Flerlage; David J Feith; Peter Chockley; Wencke Walter; Manja Meggendorfer; Thomas L Olson; HeeJin Cheon; Kristine C Olson; Aakrosh Ratan; Martha-Lena Mueller; James M Foran; Laura J Janke; Chunxu Qu; Shaina N Porter; Shondra M Pruett-Miller; Ravi C Kalathur; Claudia Haferlach; Wolfgang Kern; Elisabeth Paietta; Paul G Thomas; M Madan Babu; Thomas P Loughran; Ilaria Iacobucci; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2022-05-05       Impact factor: 41.307

2.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

Review 3.  Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors:  Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2016-08-01       Impact factor: 7.842

4.  A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.

Authors:  Takahiro Tanahashi; Nodoka Sekiguchi; Kazuyuki Matsuda; Akihiro Matsumoto; Toshiro Ito; Hideyuki Nakazawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

5.  Natural Killer Cell Lymphoma: A Case with Classification Dilemma.

Authors:  Ankit Kumar Jitani; Yookarin Khonglah; Ritesh Kumar; Bidyut Bikash Gogoi; Ekta Jajodia
Journal:  J Clin Diagn Res       Date:  2016-02-01

6.  Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.

Authors:  Cédric Pastoret; Fabienne Desmots; Gaëlle Drillet; Simon Le Gallou; Marie-Laure Boulland; Alexia Thannberger; Anne-Violaine Doncker; Véronique Salaun; Gandhi Laurent Damaj; Richard Veyrat-Masson; Olivier Tournilhac; Aline Moignet; Céline Pangault; Mikaël Roussel; Thierry Fest; Thierry Lamy
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

7.  Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.

Authors:  Gregorio Barilà; Antonella Teramo; Giulia Calabretto; Chiara Ercolin; Elisa Boscaro; Valentina Trimarco; Samuela Carraro; Matteo Leoncin; Cristina Vicenzetto; Anna Cabrelle; Monica Facco; Francesco Piazza; Gianpietro Semenzato; Renato Zambello
Journal:  Blood Cancer J       Date:  2018-06-05       Impact factor: 11.037

Review 8.  Toward a Better Classification System for NK-LGL Disorders.

Authors:  Gaëlle Drillet; Cédric Pastoret; Aline Moignet; Thierry Lamy; Tony Marchand
Journal:  Front Oncol       Date:  2022-02-01       Impact factor: 6.244

9.  Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).

Authors:  Youssef Salama; Fang Zhao; Jennifer L Oliveira; Ji Yuan; Dragan Jevremovic; Ronald S Go; Wei Ding; Sameer A Parikh; Mithun V Shah; Paul J Hampel; Aref Al-Kali; William G Morice; Min Shi
Journal:  Blood Cancer J       Date:  2022-02-22       Impact factor: 9.812

10.  A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior.

Authors:  Min Shi; Natasha M Savage; Huda Salman; William G Morice
Journal:  Clin Case Rep       Date:  2015-08-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.